Evaluation of a New Cardiac Biomarker Assay
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1101 participants.
Also called NCT01608100
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Phase 3
- Enrolled
- 1,101 participants
- Sponsor
- Abbott Diagnostics Division
- Registry
-
NCT01608100
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01608100. Allocation not applicable; no masking; primary purpose diagnostic. Start 2012-06 (registry gives no type); primary completion 2014-08 (actual). Results posted on 2015-03-17.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of a New Cardiac Biomarker Assay
- Condition
- Acute Coronary Syndrome
- Condition
- Acute Myocardial Infarction
- Intervention (Device)
- ARCHITECT STAT High Sensitive Troponin I Assay
- Lead sponsor
- Abbott Diagnostics Division
Record details
- Record id
cardio:ct-nct01608100- Content hash
6af7160abd5f68dde54bb4981ce6d37a293a415a85c916421db30195744a7db9